News

Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
Vinay Prasad—the controversial head of vaccine regulation at the US Food and Drug Administration (FDA)—has been named FDA chief medical and scientific officer.1 Traditionally separate roles, his new ...
Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...
FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been ...
When Americans imagine the future, it always has a lot to do with flying cars, robot housekeepers, and just about anything ...
The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...
The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...
Capricor's DMD therapy Deramiocel is under FDA Priority Review with no major issues flagged; PDUFA date set for August 31, 2025.
Curay, who stepped into the role as the agency’s top drug regulator in January, is departing in July, according to an email ...
Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...
The latest shake-up at the FDA forced out the top two officials in charge of reviewing cell and gene therapies, analysts said ...
The Food and Drug Administration announced the launch of a new program to fast-track agency approvals for drug manufacturers ...